Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
EmailIphone Application    Posted: 9th August 2019
If you would like to forward this story on to a friend, simply fill in the form below and click send.
Your friend's email:
Your email:
Your name:
 
 
Send Cancel

New blood test for small redworms in horses announced
The test will be available to horse owners from September 2019.

Test will be available to horse owners from September 2019

A new blood test to help diagnose small redworms in horses, including encysted larvae, has been developed by scientists at the Moredun Research Institute (MRI).

The test will be available to horse owners from September 2019 following extensive research and will be launched by commercial partner, Austin Davis Biologics (ADB).


Professor Jacqui Matthews, who led the Matthews research group at MRI, said: “It is great to see the commercialisation of this much-needed test to support sustainable worm control in horses.

“The test fills an important gap in our diagnostic toolbox and will enable horse owners to work with their veterinarians in targeting anthelmintic treatments against cyathostomin infections and hence help protect these important medicines for the future."

MRI business development manager Rhona Macdonald added: “We are delighted that the research has led to the development of a new blood test to help diagnose small redworms in horses and that the test is now available through Austin Davis Biologics.”


The new service provision marks the first phase in developing the blood test for commercialisation. 


Dr Corrine Austin of ADB said: “We are thrilled to be making this test available to horse owners after extensive research has been conducted to achieve high accuracy. ADB are now developing laboratory ELISA [enzyme-linked immunosorbent assay] kits to enable independent veterinary laboratories to conduct blood testing. 


“These kits are expected to reach market during 2020. Research into the saliva-based test is ongoing and is expected to be commercialised several years from now.”

Veterinary practices interested in the diagnostic test service can register their interest at info@austindavis.co.uk

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
Lords Committee opens Pet Parasite Medication inquiry

The House of Lords Environment and Climate Change Committee will launch its inquiry into Pet Parasite Medication (PPM) on Wednesday (3 June).

Focusing on treatments containing fipronil and imidacloprid, the inquiry will seek to understand distribution pathways and the impacts of PPM use and non-use on biodiversity and human health. It will also cover current regulation, monitoring, and the potential implications for pets and their owners.

The committee will hear evidence from environmental non-governmental organisations and research institutes. The public can follow the proceedings live on Parliament TV or in person in the Palace of Westminster.